News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
684,064 Results
Type
Article (38990)
Company Profile (277)
Press Release (644797)
Section
Business (203840)
Career Advice (1988)
Deals (35358)
Drug Delivery (84)
Drug Development (80773)
Employer Resources (168)
FDA (16085)
Job Trends (14801)
News (344486)
Policy (32431)
Tag
Academia (2530)
Alliances (49041)
Alzheimer's disease (1218)
Approvals (16005)
Artificial intelligence (122)
Bankruptcy (352)
Best Places to Work (11489)
Biotechnology (196)
Breast cancer (111)
Cancer (968)
Cardiovascular disease (82)
Career advice (1658)
Cell therapy (209)
Clinical research (64000)
Collaboration (339)
Compensation (173)
COVID-19 (2523)
C-suite (85)
Data (940)
Diabetes (140)
Diagnostics (6113)
Earnings (84489)
Employer resources (146)
Events (109114)
Executive appointments (256)
FDA (16550)
Funding (301)
Gene therapy (153)
GLP-1 (566)
Government (4320)
Healthcare (18659)
Infectious disease (2602)
Inflammatory bowel disease (102)
Interviews (308)
IPO (16275)
Job creations (3624)
Job search strategy (1416)
Layoffs (410)
Legal (7849)
Lung cancer (158)
Manufacturing (159)
Medical device (13152)
Medtech (13157)
Mergers & acquisitions (19120)
Metabolic disorders (375)
Neuroscience (1462)
NextGen Class of 2024 (6497)
Non-profit (4463)
Northern California (1304)
Obesity (223)
Opinion (176)
Patents (96)
People (56159)
Phase I (19868)
Phase II (28178)
Phase III (21032)
Pipeline (320)
Postmarket research (2553)
Preclinical (8452)
Radiopharmaceuticals (234)
Rare diseases (189)
Real estate (5888)
Regulatory (21460)
Research institute (2307)
Resumes & cover letters (349)
Southern California (1163)
Startups (3560)
United States (12285)
Vaccines (541)
Weight loss (163)
Date
Today (232)
Last 7 days (1068)
Last 30 days (3276)
Last 365 days (35456)
2024 (31168)
2023 (40074)
2022 (51175)
2021 (55712)
2020 (54087)
2019 (46541)
2018 (35020)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (713)
Arizona (188)
Asia (37044)
Australia (6040)
California (2936)
Canada (1207)
China (224)
Colorado (127)
Connecticut (131)
Europe (79307)
Florida (415)
Georgia (104)
Illinois (320)
Indiana (187)
Kansas (96)
Maryland (543)
Massachusetts (2374)
Michigan (146)
Minnesota (257)
New Jersey (868)
New York (876)
North Carolina (674)
Northern California (1304)
Ohio (129)
Pennsylvania (780)
South America (1091)
Southern California (1163)
Texas (404)
Utah (84)
Washington State (335)
684,064 Results for "atreca inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Immunome Announces Completion of Purchase of Assets from Atreca
Immunome, Inc. today announced the completion of its purchase of antibodies and related assets from Atreca, Inc.
May 20, 2024
·
4 min read
Deals
Immunome to Acquire Antibody-Related Assets and Materials from Atreca
Immunome, Inc. announced that it entered into a definitive asset purchase agreement with Atreca, Inc. to acquire a collection of antibody-related assets and materials.
December 26, 2023
·
4 min read
Biotech Bay
Atreca Announces Asset Purchase Agreement for Sale of Antibody-Related Assets and Materials to Immunome
Atreca, Inc. announced that it entered into a definitive asset purchase agreement with Immunome, Inc. to sell a collection of antibody-related assets and materials.
December 26, 2023
·
7 min read
Business
Atreca Reports Third Quarter 2023 Financial Results and Announces Further Reorganization to Support Exploration of Strategic Alternatives
Atreca, Inc. reported financial results for the third quarter ended September 30, 2023, and announced that the Company is implementing a further reduction in its workforce of approximately 40% while maintaining the necessary support to continue exploring potential strategic transactions and business alternatives.
November 14, 2023
·
5 min read
Business
Atreca Announces Agreement to Terminate Lease and Departure of Chief Financial Officer Herb Cross
Atreca, Inc. announced that, as part of its ongoing efforts to lower operating expenses, the Company has entered into an agreement to terminate its lease agreement pertaining to the Company’s headquarters in San Carlos, CA, which represented approximately $13 million of annual expenditures.
September 21, 2023
·
4 min read
Business
Atreca Reports Second Quarter 2023 Financial Results and Announces Corporate Restructuring
Atreca, Inc. announced financial results for the second quarter ended June 30, 2023, and announced a corporate reorganization to reduce expenses and extend its cash runway.
August 10, 2023
·
7 min read
Business
Atreca Reports First Quarter 2023 Financial Results and Recent Corporate Developments
Atreca, Inc. (Atreca) (NASDAQ: BCEL) today announced financial results for the first quarter ended March 31, 2023 and provided an overview of recent developments.
May 10, 2023
·
5 min read
Business
Atreca Reports Fourth Quarter and Full-Year 2022 Financial Results and ATRC-101 Data Update
Atreca, Inc. (Atreca) (NASDAQ: BCEL) today announced financial results for the fourth quarter and full-year ended December 31, 2022, and provided an overview of recent developments.
March 29, 2023
·
13 min read
Biotech Bay
Atreca to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference
Atreca, Inc. today announced that John A. Orwin, President and Chief Executive Officer, will be participating in a panel discussion on T-Cells and “Informative B-Cells” at the Canaccord Genuity Horizons in Oncology Virtual Conference.
April 13, 2023
·
2 min read
Drug Development
Atreca Announces Oral Presentation of ATRC-101 Phase 1b Study Data at ASCO 2023 Annual Meeting
Atreca, Inc. (Atreca) (NASDAQ: BCEL) today announced that data from the Phase 1b study of ATRC-101 will be presented during an oral abstract session at the American Society of Clinical Oncology 2023 Annual Meeting, being held June 2-6, 2023 in Chicago, Illinois.
April 26, 2023
·
2 min read
1 of 68,407
Next
